CSIMarket
 
Novocure Limited  (NASDAQ: NVCR)
 

Novocure Limited's Suppliers Performance

NVCR's Supply Chain




 
NVCR Costs vs Sales of Suppliers Growth Novocure Limited's cost of sales deteriorated by -0.88 % year on year, sequentially cost of sales grew by 5.59 % in Q2.

• More on NVCR Suppliers



Novocure Limited's cost of sales deteriorated by -0.88 % year on year, sequentially cost of sales grew by 5.59 % in Q2.

• More on NVCR Suppliers




Novocure Limited's Comment on Supply Chain


The company outsources production of all system components to qualified partners and maintains supply agreements with third-party manufacturers. Disposable array manufacturing constitutes the primary activity within the manufacturing supply chain, involving specialized processes. Durable system components are produced using standard electronic medical device methodologies. Certain critical materials are currently sourced from single suppliers in specific jurisdictions; however, the company is developing or obtaining regulatory approval for alternative sources in all jurisdictions. Safety stocks of single-source components are maintained to mitigate supply chain disruptions. The company expects that diversifying its supply chain will enhance supply continuity and reduce costs.

Novocure Limited's Comment on Supply Chain


The company outsources production of all system components to qualified partners and maintains supply agreements with third-party manufacturers. Disposable array manufacturing constitutes the primary activity within the manufacturing supply chain, involving specialized processes. Durable system components are produced using standard electronic medical device methodologies. Certain critical materials are currently sourced from single suppliers in specific jurisdictions; however, the company is developing or obtaining regulatory approval for alternative sources in all jurisdictions. Safety stocks of single-source components are maintained to mitigate supply chain disruptions. The company expects that diversifying its supply chain will enhance supply continuity and reduce costs.







NVCR's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Novocure Limited 1,836.48 699.19 -148.57 1,605
SUBTOTAL 0.00 0.00 0.00 -


Sources: Novocure Limited's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Novocure Limited’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.